Clostridial neurotoxins, including tetanus and botulinum neurotoxins, generally target vertebrates. We show here that this family of toxins has a much broader host spectrum, by identifying PMP1, a clostridial-like neurotoxin that selectively targets anopheline mosquitoes. Isolation of PMP1 from Paraclostridium bifermentans strains collected in anopheline endemic areas on two continents indicates it is widely distributed. The toxin likely evolved from an ancestral form that targets the nervous system of similar organisms, using a common mechanism that disrupts SNARE-mediated exocytosis. It cleaves the mosquito syntaxin and employs a unique receptor recognition strategy. Our research has an important impact on the study of the evolution of clostridial neurotoxins and provides the basis for the use of P. bifermentans strains and PMP1 as innovative, environmentally friendly approaches to reduce malaria through anopheline control.
Malaria continues to impact populations with significant deaths worldwide. Various approaches used to attenuate this disease’s incidence include the control of Anopheles mosquito species that vector plasmodium transmission. Presently, chemical insecticides are the main stay of such vector control programs, although the development of resistance has impacted their use. Biological approaches used in vector control can be effective, as evidenced by successful intervention of Onchocerca parasitic worm transmission in West Africa using Bacillus thuringiensis israelensis (Bti)1. In its over two-decade use controlling Simulium blackflies, no resistance was observed to Bti, but this biological is not effective against anophelines.
With the aim to identify additional biologicals, Paraclostridium bifermentans subsp. malaysia (Pbm) was isolated from a mangrove swamp soil in Malaysia and this strain has high mosquitocidal activity primarily to Anopheles2, even though the P. bifermentans (Pb) type strain is not mosquitocidal. Pbm is innocuous to mammals, fish, and non-target invertebrates3. Unfortunately, the lack of knowledge about the toxins involved in the mosquitocidal activity prevents its utilization as a bioinsecticide.
Previous attempts to characterize Pbm toxic components led to the identification of Cry16 and Cry17, which have similarity to B. thuringiensis Cry toxins and two proteins with low amino acid similarity to Aspergillus fumigatus hemolysins4. These proteins, as a complex, are orally toxic to Aedes mosquito larvae but not to Anopheles, even though the Pbm strain is more toxic to Anopheles5.
Here we analyze by comparative genomics Pb mosquitocidal and non-mosquitocidal strains and show that the active component in Pbm responsible for Anopheles toxicity is a complex that contains a clostridial neurotoxin (CNT) that has high selectivity to anopheline mosquitoes, acquired through a megaplasmid.
Genome sequencing of C. bifermentans strains
To identify mosquitocidal components, we sequenced genomes of two Pb mosquitocidal strains Pbm and Pb paraiba (Pbp)6, which show higher selectivity to Anopheles than Aedes mosquitoes (Supplementary Table 1), and the non-mosquitocidal Pb, Pbm, Pbp, and Pb genomes have similar chromosome sizes and belong to the group of extremely low GC clostridia, with 28% content (Supplementary Table 2, Supplementary Fig. 1A).
Eight extra scaffolds from Pbm sequencing data did not match chromosomic sequences. PCR amplification from these scaffolds’ ends confirmed their circularity, and identified them as the Pbm plasmids. Similarly, PCR confirmed the presence of five Pbp and two Pb plasmids. Notably, the mosquitocidal strains share four plasmids, which were not present in non-mosquitocidal Pb (Table 1).
Pbm toxicity is linked to a plasmid with two toxin loci
Loss of function Pbm mutants were generated by γ-irradiation. A mutant, Pbm∆109, which completely lost toxicity against Aedes and Anopheles larvae, was sequenced. Data showed that this non-toxic mutant lost four Pbm plasmids, which are also present in Pbp (Table 1). A 109 kb plasmid was analyzed (Fig. 1a, Supplementary Data 1) and contained cry16A/17A and hemolysin-like genes in a cry operon, previously characterized4,5. We found a second toxin locus (ptox) (Fig. 1a) flanked by insertion sequences and transposon elements. This locus encodes a protein, which we named paraclostridial mosquitocidal protein 1 (PMP1), with high similarity to CNTs, a group that includes the tetanus neurotoxin (TeNT) and botulinum neurotoxins (BoNTs). Recently, similar putative BoNT genes were reported in non-clostridial species from Weissella (BoNT-Wo) and Enterococcus (BoNT-En)7,8,9. The ptox locus has genes, which encode for non-toxic non-hemagglutinin (NTNH), OrfX1, OrfX2, OrfX3, PMP1, and P47 proteins, and a putative metallophosphatase family protein (MPP) (Fig. 1b).
BoNTs characterized to date mainly affect mammals and avian populations to various degrees, with BoNTs A, B, and E the main agents of human botulism, whereas BoNTs C and D are preponderant in cattle10. BoNTs intoxicate mainly by ingestion, thus they resist extreme pH and gut proteolysis to reach the bloodstream and then the nerve terminals11. Following receptor binding, the toxin is endocytosed and the acidic vesicular pH causes a conformational change that mediates translocation of the light chain (LC) within the neuron cytosol where LC, a zinc endopeptidase, cleaves its target SNARE proteins12. In the gut, BoNTs travel as high-molecular-weight complexes with associated protein components, like NTNH and the HA proteins, which stabilize the toxin13 and promotes crossing of the host intestinal barrier14,15,16. The function of the OrfX proteins remains unknown; however, recent structural information suggests they may be involved in lipid interactions17,18.
Pbm NTNH, OrfX1–3, PMP1, and P47 proteins have 35–57% amino acid identity to Clostridium proteins. PMP1’s closest relative is BoNT/X from C. botulinum strain 111 (36% identity)19, followed by BoNT/En, the Enterococcus BoNT-like protein7,9 (34% identity) (Fig. 1c, Supplementary Fig. 1B). PMP1 presents the conserved SxWY motif in the binding domain (HC), which in BoNTs is involved in ganglioside receptor binding (Fig. 1d, Supplemenatry Fig. 1C), as well as the conserved disulfide bond that links the toxin heavy and light chains, and is essential for toxicity20. The zinc-coordinating motif HExxH, which confers the LC its metalloprotease activity is also conserved (Fig. 1d, Supplementary Fig. 1D).
The ptox locus has a gene organization with an OrfX1–3 gene cluster located between NTNH and PMP1 under the same promoter (Fig. 1b). This configuration, which differs from other CNT loci, suggests that the horizontal gene transfer to Pbm or Pbp likely occurred from an ancestral bacterium as speculated for the Enterococcus BoNT-like cluster20.
Pmp operon proteins show oral toxicity to Anopheles larvae
PMP1 was immunodetected as a ~140 kDa protein in Pbm cultures (Supplementary Fig. 2A). High molecular complexes from Pbm were concentrated21 and the sample, which contained PMP1 and Cry16A (Supplementary Fig. 2B), was separated by native PAGE, subjected to analysis by ultra-performance liquid chromatography-tandem mass spectrometer (UPLC/MS/MS), and compared with a similar extracted fraction from the Pbm∆109 mutant (Supplementary Fig. 2C, 1st lane, Fig. 2a). All proteins from the cry and ptox loci were detected in the extracted Pbm sample (Supplementary Table 3), but as expected, absent in Pbm∆109. Since proteins from the cry locus are inactive against Anopheles mosquitoes5, our data provide strong evidence that proteins encoded by the ptox locus are responsible for the larvicidal activity to Anopheles.
To verify that the pmp1 operon encodes the anopheline active toxin, we expressed these proteins in different combinations in B. thuringiensis 4Q7 strain (Fig. 2b). The Bt cultures expressing either PMP1 or NTNH protein alone had no toxicity to Anopheles coluzzi. However, cultures expressing both NTNH and PMP1 proteins showed 33% mortality, whereas the one expressing the full operon (Supplementary Fig. 2C, 2nd lane) had 70% mortality (Fig. 2b). Hence, the NTNH protein likely protects the PMP1 toxin from degradation in the gut, a mechanism common among BoNT complexes22. The OrfX1–3 proteins could also act similarly and/or facilitate PMP1 toxin absorption in the gut, since increased activity is observed in their presence than in their absence (Fig. 2b). Importantly, our data show a role in toxicity for the OrfX proteins. None of the constructs was significantly toxic to Ae. aegypti. Thus, the selectivity observed in Pbm to Aedes is likely produced by the cry operon alone5.
The toxicity of Bt expressing the pmp operon is lower than that of wild-type Pbm. Potentially other proteins in the megaplasmid may contribute to the anopheline toxicity. Alternatively, differences in toxin stability and/or differences in toxin availability in Pbm and Bt contribute to the lower toxicity of the latter.
PMP1 is toxic to mosquito larvae in vivo
To evaluate if PMP1 alone is toxic when the gut barrier is by passed, we injected recombinant PMP1 into mosquito larvae (Fig. 2c). Strikingly, injected PMP1 was toxic to both Aedes and Anopheles mosquitoes with an LD50 of 14 pg (98 amol) and 6.5 pg (44.5 amol) per larva, respectively. The toxicity observed is 10–100 times greater than that of spider toxins that were also injected23.
Aedes larvae injected with the LC99 (54 pg/larva) fully recovered from the injection, but at 3 h showed significant slowing of motion (Fig. 2d, Supplementary Movie 1), consistent with the paralysis associated with CNTs’ intoxication. PMP1 was also toxic to adult mosquitoes by injection, since a dose-dependent impairment in their ability to fly was observed (Fig. 2e). Pre-incubation of the toxin with the metalloprotease inhibitor 1,10-phenanthroline before injection decreased PMP1 toxicity (Fig. 2f). Further, the mutation E209Q in the metalloprotease active site (HExxH motif) abolished activity (Fig. 2c), which confirms that PMP1 is a metalloprotease and this activity is essential for toxicity.
Since PMP1 is toxic to both mosquito species by injection, we determined if its specificity extends to other diptera or mammals once the gut barrier is bypassed. Although Pbm culture was not toxic by feeding to Drosophila larvae and adults (Supplementary Table 1), recombinant PMP1 was toxic to adult flies by injection (Fig. 2e). Further, PMP1 shows no toxicity to mice by the Digit Abduction Score assay and by intraperitoneal injections.
PMP1 cleaves mosquito syntaxin
LC metalloprotease activity is specific for one of the three neuronal SNARE proteins in mammals and their cleavage prevents neuro-exocytosis. In particular, VAMP-2/n-synaptobrevin is the target of TeNT and BoNTs B, D, F, G, X19,24,25,26, BoNT/Wo, and BoNT/En9,27, while syntaxin 1 is the target of BoNT/C and SNAP-25 is cleaved by BoNTs A, C, and E and BoNT/En9,28,29. To determine if PMP1 can cleave one of these SNARE protein homologs in mosquitoes, we incubated recombinant Anopheles gambiae syntaxin1A, n-synaptobrevin, and SNAP-25 with PMP1 LC. Only the C terminus of mosquito syntaxin was cleaved by PMP1 LC but not by the catalytically inactive PMP1 LC E209Q mutant (Fig. 3a). Interestingly, PMP1 LC was unable to cleave the recombinant human syntaxin1A (Fig. 3a), the C terminus of which is identical in mouse, and hence consistent with the lack of toxicity of PMP1 to mice.
To determine the PMP1 cleavage site, a peptide of ~4.5 kDa released from syntaxin cleavage (Fig. 3b) was purified and analyzed by UPLC-MS/MS and the peptide HAMDYVQTATQDTKK was detected (Supplementary Fig. 3B). Since Anopheles syntaxin1A C terminus is rich in positive charges, making it difficult for MS/MS detection, a syntaxin mutant (syxΔ2myc), where the charged region was deleted and an additional myc tag added, was created and similarly analyzed (Supplementary Fig. 3A). MS/MS identified peptides from the C terminus of syntaxin from H255 (Supplementary Fig. 3B). Thus, PMP1 LC cleaves syntaxin between E254 and H255 releasing a peptide that matches the observed size (Fig. 3b).
PMP1 does not cleave human syntaxin despite the cleavage site being conserved (Fig. 3c). However, a region closer to the C terminus shows sequence variation between human and mosquito syntaxins that could potentially influence substrate recognition. Indeed, CNTs are known to have an extensive substrate length requirement that involve multiple exosites away from the catalytic pocket30. To test this hypothesis, we generated Anopheles syntaxin single or double mutants where we changed amino acids in this region to the corresponding residues in human syntaxin (Fig. 3c) and incubated with PMP1 LC. These mutants cleaved less efficiently than Anopheles syntaxin, and L271V completely abolished cleavage (Fig. 3a). The presence of non-polar amino acids, such as valine in human syntaxin C terminus, likely disrupts the interaction with PMP1 LC and prevents cleavage.
Canonical CNT GBS is not critical for PMP1 mosquito toxicity
CNTs bind to the presynaptic membrane of peripheral nerve terminals with high specificity31. Polysialogangliosides recruit and concentrate CNTs, while specific proteins such as associated vesicle protein 2 (SV2) or synaptotagmin have been described as cell entry mediators12. A conserved ganglioside-binding site (GBS), which contains the SxWY motif has been identified in the C terminus of BoNT/A, B, E, F, G, X and TeNT HC, where the tryptophan is essential in maintaining hydrophobic interactions with the ganglioside sugar and is involved in toxicity32. Notably, PMP1 also shares a SGWY motif in the corresponding site, and a tandem repeat in front (Fig. 1d, Supplementary Fig. 1C).
To analyze if the SxWY motif is involved in toxicity and to determine the presence of other cell recognition regions, recombinant PMP1 HC was crystallized (residues 825–1260) and its structure determined at 1.95 Å resolution (Table 2). PMP1 HC has a fold similar to other CNTs33 and a well-conserved secondary structure (Fig. 4a, Supplementary Fig. 4A, B) despite having <30% sequence identity. PMP1 HC includes two subdomains, a N-terminal lectin-like fold (HCN) consisting primarily of 15 β-strands arranged in a jelly-roll fold and a C-terminal β-trefoil fold mostly composed of seven pairs of β-strands linked by loops (HCC) (Fig. 4a). The HCC is the main region associated with cell recognition, and in PMP1, presents the most structural variation compared to other CNTs. One striking feature of PMP1 HCC is its general hydrophobicity, with an array of a dozen aromatic residues exposed on its surface (Fig. 4b) and its lack of clear binding pockets (Supplementary Fig. 4C). The SxWY motif (S1229, W1231, and Y1232) is in a shallow pocket flanked on one side by a short lysine-rich α-helix (1242–1246) that is unique to PMP1 and may prevent the binding of gangliosides with branched carbohydrate head groups (Fig. 4b, Supplementary Fig. 4C).
Of particular interest are the three extended loops found almost in parallel in the HCC subdomain. Extended loops 1094–1099 (loop 1), 1164–1172 (loop 2), and 1202–1208 (loop 3) (Fig. 4b) present bulky hydrophobic side chains. Loops 1 and 2 come close to each other with E1099 making a salt bridge with K1168 (Fig. 4b), at a location where BoNT/B and TeNT bind synaptotagmin and disialyllactose or a tri-peptide, respectively34 (Supplementary Fig. 4C), suggesting a different cell recognition mechanism for PMP1. A fourth loop composed of residues 1213–1222 (loop 4) was disordered, but seems to occupy a different position compared to the equivalent loops in BoNT/B and TeNT that are more protuberant. This loop was recently shown to play an essential role in lipid bilayer insertion for BoNT/B, DC, and G19,35.
The toxicity of PMP1 HC mutants was tested by injecting an LC99 dose into A. aegypti larvae (Fig. 4c). Remarkably, W1231A and W1224A mutations of the tandem SxWY motifs did not decrease toxicity (Fig. 4c). The mutation of S1229, which disrupts ganglioside binding in BoNTs36, did not affect toxicity either (Fig. 4c). Mutation of an exposed F1202 in loop 3 did not decrease toxicity, but other mutations on loops 1 to 3 decreased toxicity to different extents. We observed a slight reduction in the quadruple mutants of loops 2 and 3 (K1168A/I1169A/K1170A/E1171A and M1165A/Y1166D/M1204A/Y1205D) and a strong reduction to 8% mortality in the quadruple mutant of loop 1 (S1095A/W1096A/Y1097A/G1098A) (Fig. 4c). Interestingly, mutation of Trp alone (W1096A) in loop 1 strongly decreased the toxicity to 30%. In addition, the mutant affecting a surface-exposed tyrosine hydrophobic patch (Y1100D/Y1101D/Y1173A/Y1227A) also nearly abolished toxicity (Fig. 4c, Supplementary Fig. 4).
Our data suggest that the canonical SxWY motif included in the GBS is not essential for toxicity. Instead, a similar motif, SWYG, located in loop 1 of the HC C terminus is critical, with an important role for the tryptophan in this loop.
Our data support an event of plasmid acquisition by the non-mosquitocidal Pb-type strain. The mosquitocidal strains Pbm and Pbp share a similar genome with Pb, but contain extra plasmids and in particular a megaplasmid with two toxin loci that provides toxicity to mosquito species. The isolation of these strains from anopheline endemic areas provides strong evidence of an example of insect–bacteria coevolution. Notably, both strains, isolated from Malaysia and Brazil, respectively, share a nearly identical megaplasmid, although originally from distant locations. Thus, it is likely that similar bacterial strains can be isolated from other locations populated with Anopheles species, facilitating the use of native strains for Anopheles control programs in these areas.
Our results show for the first time that the operon-associated OrfX proteins play a role in the toxicity of a CNT. As with mammalian BoNT, the Pbm NTNH increases the toxicity of PMP1. Oral toxicity appeared specific to Anopheles mosquitoes, and might be linked to the inability of PMP1 to cross the midgut barrier in Aedes and Drosophila. It is possible that the OrfX cluster, encoded in the pmp operon, aids PMP1 absorption through the Anopheles larvae midgut, but not in other insect species tested.
PMP1 exerts its action through its metalloprotease activity on a SNARE protein in a typical BoNT-like fashion, as demonstrated by mutagenesis of the catalytic site and decreased toxicity observed in the presence of a metalloprotease inhibitor. Additionally, the mutation E209Q abolished PMP1’s ability to cleave Anopheles syntaxin1A, a highly conserved neuronal protein. Key differences in the sequence of human/mouse syntaxin prevent its cleavage by PMP1. Our data shows that residues, which are key for PMP1 LC cleavage, are shared by dipteran species, including Drosophila, and some are shared among invertebrates but are absent in vertebrates, mammals, and fish (Fig. 3c). Whether PMP1 is toxic to other invertebrates by injection besides mosquitoes and Drosophila needs investigation. Nevertheless, the toxicity of injected PMP1 to the species tested matches the ability of PMP1 LC to cleave syntaxin. However, at this stage we cannot exclude the possibility that PMP1 cleaves other proteins and that the lack of mouse toxicity was due to the inability of PMP1 to bind or cross the mammalian neuronal membrane. Further research about the interaction between the toxin and the nervous system cell membranes in different species is needed to fully elucidate the mechanism of PMP1 internalization.
The structure of PMP1 HC shows significant differences in comparison to the structures of other CNTs. PMP1 is the first example of a CNT where the SxWY motif, although conserved, is not implicated in toxicity. Our data propose that the unique PMP1 HC hydrophobicity and a SWYG motif in loop 1 are important determinants of toxicity. In BoNT/C the SxWY motif is not conserved and one of the two GBS is located on an exposed loop37. It was proposed that some BoNTs interact directly with lipid membranes via hydrophobic interactions through an extended loop (loop 4)19. PMP1 also has hydrophobic domains that could facilitate similar interactions. However, it is possible that loop 1 (SWYG) interacts with specific mosquito midgut receptors akin to that observed with the specificity observed with insecticidal B. thuringiensis toxins38.
The toxicity of recombinant BoNT/X from C. botulinum strain 111 to mice by injection is very low19. The Enterococcus BoNT-like protein shows no toxicity to mice, although it cleaves human VAMP-2 and SNAP-25 in neurons. BoNT/X and BoNT/En represent two members of a lineage of BoNTs7,9 the specificities of which are unknown (Fig. 1b). Here we reveal that PMP1 is a member of this lineage and targets Anopheles mosquito larvae. PMP1 is thus the first CNT that targets invertebrates. Hence, clostridial-like toxins with low mammalian toxicity have organismal targets that are yet unidentified and focusing only on mammalian or vertebrate targets could be misleading. It is likely these toxins co-evolved with their target host, as observed here for PMP1 with anopheline mosquitoes.
We believe our contribution has very important implications about the evolutionary origin of CNTs. Broadening the range of CNTs specificity found in Clostridium and non-Clostridium species will be useful, not only for medical applications but also for novel biotechnological purposes.
As an example, Pbm could be formulated together with other mosquitocidal strains or the Pbm toxin genes incorporated into another strain. Both approaches would increase the spectrum of activity of currently used biological insecticides. However, a more attractive alternative could be to use locally isolated Pb mosquitocidal strains. As Pb is an anaerobe such mosquitocidal cultures can be readily made in rural areas with minimal inputs. These crude cultures can then be used for suppression of larval anophelines.
We open a field for targeting pests, pathogens, or vectors of diseases with a mode of action that might delay the appearance of resistance in an environment-friendly system.
Anopheles coluzzi, Anopheles stephensi, and Ae. aegypti mosquito larvae were reared at 28 °C with a photoperiod of 16:8 h light/darkness in distilled water and fed with 1:4 yeast/fish food.
Bacterial strains and culture conditions
Paraclostridium bifermentans (ATCC 638) from the American Type Culture Collection was used as the wild-type reference strain, and P. bifermentans subsp. malaysia and P. bifermentans subsp. paraiba were from the collection of the Institute for Medical Research, Malaysia39. Bacteria were grown in liquid tryptone-yeast extract-glucose (TYG) medium at 30 °C under anaerobic conditions using BD GasPakEZ (Becton-Dickinson Microbiology).
Bacillus thuringiensis israelensis (Bti) 4Q5 strain from Bacillus Genetic Stock Center was grown overnight at 30 °C in sporulation media (0.8% Nutrient broth, 1 mM MgSO4, 13 mM KCl, 10 μM MnCl2, 0.5 mM CaCl2) with shaking until complete autolysis.
Different volumes of Pbm or Bti whole bacterial cultures were tested at room temperature in 100 ml water cups containing 20 third instar mosquito larvae. Bioassays were repeated at least three times.
To test the toxicity of PMP1, NTNH, NTNH-PMP1, and NTNH-OrfX1-3-PMP1 constructs, B. thuringiensis subsp. israelensis 4Q7 cells (Bacillus Stock Center, Ohio State University, Columbus, OH, USA) transformed strain was grown overnight at 30 °C in sporulation media with 50 μg/ml erythromycin and a 100× dilution in bioassay water cups was used. The experiment was repeated six times for the control construct, five times for PMP1 and NTNH-PMP1, four times for NTNH-OrfX1-3-PMP1, and twice for NTNH construct. Mortality was assessed after a 3-day exposure. To determine the LC50 of the NTNH-OrfX1-3-PMP1 varying levels of the bacterial culture was added to 100 ml bioassay cups and the mortality was assessed after a 3-day exposure. The LC50 were determined by probit analysis (SPSS). This determination was performed twice.
Pb malaysia mutagenesis
A Pb malaysia overnight culture was diluted 1:30 in TYG media and grown for 6 h in anaerobic conditions. The cells were exposed to a 137Cesium source (J.L. Shepherd and Associates) for 6 min. Irradiated cells were diluted 1:100 and grown overnight at 30 °C in anaerobic conditions on TYG plates. Individual cells were selected and grown in liquid TYG for toxicity screening. Screening of 3000 colonies was performed using three Aedes 2nd instar larvae in 1 ml water in 24-well polystyrene plates and toxicity was recorded after 24 h. The three mutants that lost completely their toxicity to A. aegypti were then bioassayed with An. stephensi larvae and one mutant Pbm∆109 selected for further analysis.
PAGE and immunoblotting
Proteins separated in a sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or native gel were transferred onto a PVDF membrane (Immobilon P, Millipore) and incubated overnight 4 °C with the primary antibody in blocking buffer (5% skim milk in phosphate-buffered saline (PBS)). A secondary antibody, enhanced chemiluminescence anti-rabbit IgG-horseradish peroxidase-linked whole antibody (ref. NA934 GE Healthcare, Anaheim, CA, USA), was used at a 1:5000 dilution. Immunoreactive bands were visualized using the SuperSignal West Dura Extended Duration Substrate (Thermo Fisher). Rabbit antibodies against the PMP1 peptide in the heavy chain (GFENIDFSEPEIRY) was produced (GenScript, Piscataway, NJ, USA) and used at a 1:3000 dilution.
Genomic DNA isolation
For genome sequencing, total Pb malaysia, Pb paraiba, and Pb DNA were isolated using phenol–chloroform extraction protocol and Pbm∆109 was isolated using DNeasy blood and tissue kit (Qiagen) from fresh overnight cultures. Quantity and quality of the DNA were measured spectrophotometrically (Nanodrop 2000, Thermo Scientific).
Pb malaysia and Pbm∆109 proteins present in the culture supernatant were acid precipitated adding H2SO4 dropwise to pH 3.5 as described21. Precipitated proteins were extracted by agitation for 2 h in 0.1 M sodium citrate buffer pH 5.5 and analyzed in native protein acrylamide gels. Protein lanes were then excised from the gel and analyzed by mass spectrometry (LTQ Orbitrap Fusion MS coupled to 2-dimension nano-UPLC) at the Proteomics Core facility at the University of California, Riverside. Protein searches were performed against Pb malaysia genome predicted protein database.
For analyses of the cleavage site, cleavage assay mixtures after incubation were peptide purified using Sep-Pak cartridges (Waters) and analyzed by mass spectrometry similarly.
Larvae and adult injection
Fourth instar larvae were kept on ice and then injected between the head and the thorax on a Petri dish using Drummond capillary tubes and a Nanoject II auto-nanoliter injector (Drummond Scientific). Injected larvae were transferred to water cups and kept for 24 h under standard rearing conditions. Adults were injected between the thorax and abdomen and transferred to adult mosquito rearing tubes.
Forty groups of 15 A. aegypti and 42 groups of An. coluzzi larvae were injected with different doses of PMP1 from 0.02 to 30,000 amol/larva. Mortality was recorded after 24 h. For replicates of the same dose, the mortality mean was used (2 replicates of 15 larvae for all doses except 97.65 and 24.53 amol/larva, which were repeated three times; 61.65 and 38.83 amol/larva were repeated five times; and 3276.15, 727.47, 15.47, 7.27, 4.52, 0.36, and 0.003 amol/larva were repeated once). Six groups of 15 larvae were injected by PMP1 E209Q. Data were adjusted to a control background mortality of 3% for Aedes and 7% for Anopheles. The dose–mortality curve was plotted using the Origin Lab software. The PMP1-injected larvae data fitted a sigmoid dose–response curve (Hill equation). For the Aedes curve, reduced: χ2 = 79.6 and adjusted R2 = 0.935. For the Anopheles curve, reduced: χ2 = 126.8, adjusted R2 = 0.854).
To test PMP1 toxicity to adult mosquitoes and flies, the following number of individuals were injected: 58 Aedes control, 60 4 pg, 43 100 pg; 54 Anopheles control, 65 4 pg, 62 100 pg, 15 Drosophila control, 15 100 pg. Mortality rate due to injection (discarded dead individuals 1 h after injection) was between 12 and 13.9% for all Aedes experiments, including control and independent of the dose of PMP1 injected, 42.6–50.6% for Anopheles and 7.4–14.8% for Drosophila.
To test the effect of 5 mM 1,10-phenanthroline in PMP1 toxicity, the mixture was incubated for 30 min on ice before injection. The decrease of toxicity is represented as percentage in comparison to the injection of PMP1 without inhibitor. Three replicates of 15 individuals were performed for Anopheles and 4 for Aedes.
To test the toxicity of PMP1 HC mutants by injection, three replicates of 15 individuals were performed for all constructs except MY, W1, SWYG, and KIKE constructs, which were repeated four times.
Plasmid construction, protein expression, and purification
The pmp1 gene was commercially synthesized (GenScript, Piscataway, NJ, USA) using B. thuringiensis codon optimization. The ntnh-orfX1-orfX2-orfX3-pmp1 genes were amplified from Pbm whole DNA preparation using Platinum Taq high-fidelity polymerase (Thermo Fisher) and primers 1 and 2 (Supplementary Table 4) in an automated thermocycler (C 1000 Touch, Bio-Rad). Individual ntnh and pmp1 genes were amplified similarly using primers 3, 4, and 5, 6, respectively, to produce constructs NTNH and NTNH-PMP1. PCR products were separated in 1% agarose gels and subsequently cut and purified using Wizard SV gel and PCR purification kits (Promega, Madison, WI, USA). Sequencing of purified DNA products was performed by the Genomics Core facility at the University of California, Riverside. The full operon, ntnh, pmp1, and ntnh-pmp1, constructs were first subcloned into pCR2.1 TOPO TA vector (Thermo Fisher) and then cloned into pHT315 vector40 under Cyt1A promoter from B. thuringiensis israelensis (Cyt1A P) or Cry3A promoter from B. thuringiensis tenebrionis (Cry3A P) and Cry1A stem loop terminator (Cry1A SL). For expression of pmp1 gene in NTNH-PMP1 and orfX1, orfX2, orfX3, and pmp1 genes in NTNH-OrfX1-3-PMP1 construct, the native Shine–Dalgarno sequences were used. The constructs in pHT315 were transformed in Bti 4Q7 cells.
PMP1, PMP1 catalytically inactive E209Q mutant, PMP1 HC mutants, PMP1 LC, PMP1 HC, and SNARE proteins were purified from Escherichia coli. PMP1 was commercially synthesized E. coli codon optimized and cloned in pQE-30 vector (Qiagen). Fragments of PMP1 HC containing the desired mutations were individually synthesized between restriction sites RsrII and HindIII, and were inserted in PMP1 to produce PMP1 HC mutants. Catalytically inactive E209Q mutant was created by nested PCR using primers 7, 8, 9, and 10. PMP1 HC was amplified from PMP1 gene using primers 11 and 12 and cloned in pET duet 1. PMP1 LC was amplified from PMP1 gene using primers 13 and 14 and cloned in RSF duet 1. DNA sequence encoding fragments of SNARE proteins (A. gambiae VAMP-2 amino acids 1–99, syntaxin 1–268, SNAP-25 1–213, and Human VAMP-2 1–93 and syntaxin 1–266) were commercially synthesized codon optimized for E. coli expression with a myc tag added in C terminus (GenScript, Piscataway, NJ, USA) and cloned in pGEX-6P vector. Anopheles gambiae syntaxin with a His tag was amplified using primers 15 and 16 (Supplementary Table 4) from synthesized syntaxin fragment and cloned in pET Duet 1. Syntaxin mutants were produced by nested PCR, inserting the desired mutations in primers 17–28 (Supplementary Table 4).
BL21(DE3) pLysS chemically competent E. coli cells (Agilent) were transformed with genes cloned in vectors pGEX-6P, pET Duet 1, and RSF Duet 1 according to the manufacturer’s protocol. Chemically competent M15 cells (Qiagen) were used for transformation of genes cloned in pQE-30. Cells were induced by adding 1 mM isopropyl β-d-1-thiogalactopyranoside, grown in LB medium for 4 h at 25 °C, and harvested by centrifugation. Cell lysis was produced in 50 mM Tris, 300 mM NaCl, 1 mM dithiothreitol, 0.1% glycerol, 500 µg/ml lysozyme, pH 7.4, and sonicated for 3 min. PMP1 HC, PMP1, PMP1 mutants, syntaxin, and syntaxin mutants with a His tag were purified from the lysate supernatant using Ni NTA agarose beads (Qiagen). LC was purified using Flag tag affinity gel (BioLegend) and the SNARE proteins with a GST tag were purified using GST SpinTrap columns (GE Healthcare).
Recombinant A. gambiae VAMP-2/synaptobrevin, syntaxin, syntaxin mutants, SNAP-25, and human syntaxin (2 µg) were incubated in 50 mM NaH2PO4 buffer, pH 6.2, with 500 ng of LC or catalytically inactive E209Q LC for 3 h 30 °C. Samples were analyzed by SDS-PAGE and western blot and immunodetected using GST tag antibody (ref. 27457701, GE Healthcare, 1:2000 dilution), His tag antibody (ref. A00186, GenScript, 1:5000 dilution), Drosophila syntaxin antibody (ref. 8C3, Developmental Studies Hybridoma Bank, University of Iowa, 1:1000 dilution) or myc tag antibody (ref. 2272, Cell Signaling, 1:1500 dilution). Uncropped version of the western blots is provided in Source Data file.
Digit abduction assay and intraperitoneal injections
Mice, 50–55 g (n = 3), were anesthetized by intraperitoneal injection of ketamine/xylazine and after 15 min 1 μg of PMP1 in 100 μl PBS was injected into the gastrocnemius muscles of the mice left hind limb and the same volume of buffer was injected into the right hind limb of the same mouse as a control. Mice were monitored for any symptom of flaccid paralysis and ability to spread the toes for 24 h. Intraperitoneal injections were performed injecting 3.0 μg PMP1 in unanesthesized mice, 25–27 g (n = 3). Mice were monitored for mortality and visible effects for 24 h and up to 4 days. The UC Riverside animal use committee approved these protocols.
Crystals of PMP1 HC (8.4 mg/ml) were obtained from a sitting-drop vapor diffusion setup against 0.12 M ethylene glycols, 0.1 M Buffer System 3, pH 8.5, 50% v/v Precipitant Mix 4 (Morpheus screen, Molecular Dimensions, UK). A drop of 200 nl of sample was mixed with an equal amount of reservoir and incubated at 21 °C. Crystals grew within 2 weeks and were frozen in liquid nitrogen for data collection. Diffraction data were collected at a wavelength of 0.984 Å at station ID30B of the ESRF synchrotron (Grenoble, France). A complete dataset at 1.95 Å was collected from a single crystal at 100 K. Raw data images were processed and scaled with XDS41, and Aimless42 using the CCP4 suite 7.0 (CCP4, 1994). Initial phases for structure solution were obtained by molecular replacement using the MoRDa pipeline43. The working models were refined using Refmac544 and manually adjusted with Coot45. Validation was performed with Molprobity46, with 95.5% of residues within the favored Ramachandran region, and no outliers. Figures were drawn with PyMOL (Schrödinger, LLC, New York, USA).
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
The atomic coordinates and structure factors (code 6HOX) have been deposited in the Protein Data Bank. Accession numbers of CP032452 for Pbm genome and CP032455 for pPbmMP, and CP032453 and CP032454 for two other plasmid DNA sequences are available at the NCBI database (GenBank). The Pbp and Pb whole-genome shotgun projects have been deposited at DDBJ/ENA/GenBank under the accession numbers RANB00000000 and QZNC00000000, respectively. The source data underlying Figs. 2b–f, 3a, and 4c are provided as a Source Data file.
Lacey, L. A., Escaffre, H., Philippon, B., Seketeli, A. & Guillet, P. Large river treatment with Bacillus thuringiensis (H-14) for the control of Simulium damnosum s.l. in the Onchocerciasis Control Programme. Trop. Parasitol. 33, 97–101 (1982).
de Barjac, H., Sebald, M., Charles, J. F., Cheong, W. H. & Lee, H. L. Clostridium bifermentans serovar malaysia, a new anaerobic bacterium pathogen to mosquito and blackfly larvae. C. R. Acad. Sci. III 310, 383–387 (1990).
Thiery, I., Hamon, S., Gaven, B. & de Barjac, H. Host range of Clostridium bifermentans serovar. malaysia, a mosquitocidal anaerobic bacterium. J. Am. Mosq. Control. Assoc. 8, 272–277 (1992).
Barloy, F., Delecluse, A., Nicolas, L. & Lecadet, M. M. Cloning and expression of the first anaerobic toxin gene from Clostridium bifermentans subsp. malaysia, encoding a new mosquitocidal protein with homologies to Bacillus thuringiensis delta-endotoxins. J. Bacteriol. 178, 3099–3105 (1996).
Qureshi, N., Chawla, S., Likitvivatanavong, S., Lee, H. L. & Gill, S. S. The cry toxin operon of Clostridium bifermentans subsp. malaysia is highly toxic to aedes larval mosquitoes. Appl. Environ. Microbiol. 80, 5689–5697 (2014).
Seleena, P., Lee, H. L. & Lecadet, M. M. A novel insecticidal serotype of Clostridium bifermentans. J. Am. Mosq. Control. Assoc. 13, 395–397 (1997).
Brunt, J., Carter, A. T., Stringer, S. C. & Peck, M. W. Identification of a novel botulinum neurotoxin gene cluster in Enterococcus. FEBS Lett. 592, 310–317 (2018).
Mansfield, M. J., Adams, J. B. & Doxey, A. C. Botulinum neurotoxin homologs in non-Clostridium species. FEBS Lett. 589, 342–348 (2015).
Zhang, S. et al. Identification of a Botulinum neurotoxin-like toxin in a commensal strain of Enterococcus faecium. Cell Host Microbe 23, 169–176 e166 (2018).
Woudstra, C. et al. Neurotoxin gene profiling of Clostridium botulinum types C and D native to different countries within Europe. Appl. Environ. Microbiol. 78, 3120–3127 (2012).
Gu, S. et al. Botulinum neurotoxin is shielded by NTNHA in an interlocked complex. Science 335, 977–981 (2012).
Rossetto, O., Pirazzini, M. & Montecucco, C. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat. Rev. Microbiol. 12, 535–549 (2014).
Benefield, D. A., Dessain, S. K., Shine, N., Ohi, M. D. & Lacy, D. B. Molecular assembly of botulinum neurotoxin progenitor complexes. Proc. Natl. Acad. Sci. USA 110, 5630–5635 (2013).
Lee, K. et al. Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity. PLoS Pathog. 9, e1003690 (2013).
Lee, K. et al. Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex. Science 344, 1405–1410 (2014).
Sugawara, Y. et al. Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin. J. Cell Biol. 189, 691–700 (2010).
Gustafsson, R. et al. Crystal structures of OrfX2 and P47 from a Botulinum neurotoxin OrfX-type gene cluster. FEBS Lett. 591, 3781–3792 (2017).
Lam, K. H. et al. The hypothetical protein P47 of Clostridium botulinum E1 strain Beluga has a structural topology similar to bactericidal/permeability-increasing protein. Toxicon 147, 19–26 (2018).
Zhang, S. et al. Identification and characterization of a novel botulinum neurotoxin. Nat. Commun. 8, 14130 (2017).
Pirazzini, M. et al. Thioredoxin and its reductase are present on synaptic vesicles, and their inhibition prevents the paralysis induced by botulinum neurotoxins. Cell Rep. 8, 1870–1878 (2014).
Lin, G., Tepp, W. H., Bradshaw, M., Fredrick, C. M. & Johnson, E. A. Immunoprecipitation of native botulinum neurotoxin complexes from Clostridium botulinum subtype A strains. Appl. Environ. Microbiol. 81, 481–491 (2015).
Popoff, M. R. & Connan C. In Molecular Aspects of Botulinum Neurotoxin (ed. Foster, K. A.) 35–68 (Springer, New York, 2014).
Herzig V. et al. Molecular basis of the remarkable selectivity of an insecticidal sodium channel toxin from the African spider Augacephalus ezendami. Sci. Rep. 6, https://doi.org/10.1038/srep29538 (2016).
Schiavo, G. et al. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359, 832–835 (1992).
Yamasaki, S. et al. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. J. Biol. Chem. 269, 12764–12772 (1994).
Schiavo, G. et al. Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond. J. Biol. Chem. 269, 20213–20216 (1994).
Zornetta, I. et al. The first non Clostridial botulinum-like toxin cleaves VAMP within the juxtamembrane domain. Sci. Rep. 6, 30257 (2016).
Binz, T. et al. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. Biol. Chem. 269, 1617–1620 (1994).
Foran, P., Lawrence, G. W., Shone, C. C., Foster, K. A. & Dolly, J. O. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry 35, 2630–2636 (1996).
Breidenbach, M. A. & Brunger, A. T. Substrate recognition strategy for botulinum neurotoxin serotype A. Nature 432, 925–929 (2004).
Rummel, A., Mahrhold, S., Bigalke, H. & Binz, T. Exchange of the H(CC) domain mediating double receptor recognition improves the pharmacodynamic properties of botulinum neurotoxin. FEBS J. 278, 4506–4515 (2011).
Emsley, P. et al. The structures of the H(C) fragment of tetanus toxin with carbohydrate subunit complexes provide insight into ganglioside binding. J. Biol. Chem. 275, 8889–8894 (2000).
Swaminathan, S. Molecular structures and functional relationships in clostridial neurotoxins. FEBS J. 278, 4467–4485 (2011).
Jayaraman, S., Eswaramoorthy, S., Kumaran, D. & Swaminathan, S. Common binding site for disialyllactose and tri-peptide in C-fragment of tetanus neurotoxin. Proteins 61, 288–295 (2005).
Stern, D. et al. A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency. PLoS Pathog. 14, e1007048 (2018).
Rummel, A., Mahrhold, S., Bigalke, H. & Binz, T. The HCC-domain of botulinum neurotoxins A and B exhibits a singular ganglioside binding site displaying serotype specific carbohydrate interaction. Mol. Microbiol. 51, 631–643 (2004).
Strotmeier, J. et al. The biological activity of botulinum neurotoxin type C is dependent upon novel types of ganglioside binding sites. Mol. Microbiol. 81, 143–156 (2011).
Li, J. D., Carroll, J. & Ellar, D. J. Crystal structure of insecticidal delta-endotoxin from Bacillus thuringiensis at 2.5 A resolution. Nature 353, 815–821 (1991).
Lee, H. L. & Seleena, P. Isolation and evaluation of larvicidal Clostridium bifermentans against mosquitoes of public health importance. Trop. Biomed. 7, 103–106 (1990).
Arantes, O. & Lereclus, D. Construction of cloning vectors for Bacillus thuringiensis. Gene 108, 115–119 (1991).
Kabsch, W. XDS. Acta Crystallogr. D 66, 125–132 (2010).
Evans, P. Scaling and assessment of data quality. Acta Crystallogr. D 62, 72–82 (2006).
Vagin, A. & Lebedev, A. MoRDa, an automatic molecular replacement pipeline. Acta Crystallogr D. A71, s19 (2015).
Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D 67, 355–367 (2011).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).
Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12–21 (2010).
Bryant, D. & Moulton, V. Neighbor-Net: an agglomerative method for the construction of phylogenetic networks. Mol. Biol. Evol. 21, 255–265 (2004).
We thank S. Pan from the University of California Proteomic Facility for his support in mass spectrometry analysis (supported by a NIH shared instrumentation grant (S10 OD010669)) and scientists at station ID30B of ESRF (Grenoble, France) for their support during crystallography data collection. We thank Dr. Daniel Lundin for help with the phylogenetic network. The research was funded in part through grants from the National Institutes of Health, 1 R01AI123390 and 1R21AI070873, and the University of California Agricultural Experiment Station CA-R-NEU-7395-H to S.S.G. and by the Swedish Research Council (2014–5667) and the Swedish Cancer Society to P.S.
S.S.G., E.C., and J.C. have filed a provisional patent application. The other authors declare no competing interests.
Peer review information: Nature Communications thanks Michel-Robert Popoff, John Vontas and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Contreras, E., Masuyer, G., Qureshi, N. et al. A neurotoxin that specifically targets Anopheles mosquitoes. Nat Commun 10, 2869 (2019). https://doi.org/10.1038/s41467-019-10732-w
Potency and stability of a trivalent, catalytically inactive vaccine against botulinum neurotoxin serotypes C, E and F (triCEF)
Microbial Biotechnology (2020)
Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy
PLOS Biology (2020)